@article{TBCR61051,
author = {Tao Wang and Pin Zhang and Lijun Di and Xiaojia Wang and Junlan Yang and Zhongsheng Tong and Jian Liu and Jifeng Feng and Donggeng Liu and Qitao Yu and Yunpeng Liu and Hao Yu and Zefei Jiang},
title = {Efficacy and safety of inetetamab in combination with chemotherapy as first-line treatment of HER2-positive metastatic breast cancer: a subgroup analysis in the HOPES study},
journal = {Translational Breast Cancer Research},
volume = {3},
number = {0},
year = {2022},
keywords = {},
abstract = {},
issn = {2218-6778}, url = {https://tbcr.amegroups.org/article/view/61051}
}